|
|
|
Insider
Information: |
Davis Stephen |
Relationship: |
Director |
City: |
Branford |
State: |
CT |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
344,117 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,595,864 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
344,117 |
|
|
Total
Value |
$2,595,864 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
16
|
Stock
price went up :
|
0
|
7
|
Stock
price went down : |
0
|
9
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-98.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Heron Therapeutics Inc |
HRTX |
Director |
2022-12-16 |
52,032 |
2010-02-17 |
0 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
EVP & COO |
2012-06-19 |
0 |
2010-04-06 |
0 |
Premium* |
|
Furiex Pharmaceuticals, Inc. |
FURX |
Director |
2014-07-02 |
0 |
2013-05-24 |
0 |
Premium* |
|
Acadia Pharmaceuticals Inc |
ACAD |
|
2024-05-02 |
155,231 |
2019-10-09 |
0 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
Director |
2023-01-03 |
136,854 |
2022-01-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
95 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RDEA |
Ardea Biosciences Inc |
EVP & COO |
|
2011-08-06 |
4 |
D |
$18.22 |
$3,480 |
D/D |
(191) |
18,460 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2023-02-24 |
4 |
S |
$18.78 |
$72,322 |
D/D |
(3,851) |
91,727 |
0 |
% |
|
RDEA |
Ardea Biosciences Inc |
EVP & COO |
|
2011-11-06 |
4 |
D |
$18.81 |
$3,593 |
D/D |
(191) |
17,187 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
EVP & COO |
|
2011-11-15 |
4 |
AS |
$18.86 |
$8,146 |
D/D |
(432) |
17,331 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2019-10-09 |
4 |
OE |
$19.65 |
$585,413 |
D/D |
29,792 |
29,792 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2019-10-10 |
4 |
OE |
$19.65 |
$2,362,087 |
D/D |
120,208 |
120,208 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2019-12-05 |
4 |
OE |
$19.65 |
$2,947,500 |
D/D |
150,000 |
152,954 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2020-05-13 |
4 |
OE |
$19.65 |
$2,190,150 |
D/D |
111,458 |
123,267 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2020-05-14 |
4 |
OE |
$19.65 |
$1,739,850 |
D/D |
88,542 |
100,351 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
EVP & COO |
|
2011-12-06 |
4 |
D |
$19.93 |
$3,807 |
D/D |
(191) |
17,140 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
EVP & COO |
|
2012-02-06 |
4 |
D |
$20.20 |
$4,404 |
D/D |
(218) |
16,004 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
EVP & COO |
|
2012-03-06 |
4 |
D |
$20.33 |
$4,330 |
D/D |
(213) |
15,791 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2021-04-30 |
4 |
S |
$20.33 |
$159,591 |
D/D |
(7,850) |
49,312 |
0 |
% |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2023-07-14 |
4 |
OE |
$20.77 |
$2,077,000 |
D/D |
100,000 |
136,695 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2023-05-01 |
4 |
S |
$21.18 |
$165,331 |
D/D |
(7,806) |
108,297 |
0 |
% |
|
RDEA |
Ardea Biosciences Inc |
EVP & COO |
|
2010-11-22 |
4 |
AS |
$21.92 |
$7,693 |
D/D |
(351) |
25,117 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
EVP & COO |
|
2012-04-06 |
4 |
D |
$21.92 |
$4,187 |
D/D |
(191) |
15,600 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2023-10-06 |
4 |
S |
$21.96 |
$1,132,323 |
D/D |
(51,563) |
89,131 |
0 |
% |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2022-01-06 |
4 |
S |
$23.05 |
$85,700 |
D/D |
(3,718) |
58,716 |
0 |
% |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2022-02-23 |
4 |
S |
$23.80 |
$93,486 |
D/D |
(3,928) |
65,733 |
0 |
% |
|
RDEA |
Ardea Biosciences Inc |
EVP & COO |
|
2011-06-06 |
4 |
D |
$23.94 |
$4,596 |
D/D |
(192) |
19,542 |
0 |
- |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2024-02-26 |
4 |
AS |
$24.67 |
$137,585 |
D/D |
(5,577) |
101,890 |
0 |
% |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2023-07-11 |
4 |
AS |
$25.00 |
$412,450 |
D/D |
(16,498) |
91,799 |
0 |
% |
|
ACAD |
Acadia Pharmaceuticals In... |
CEO |
|
2023-07-12 |
4 |
AS |
$25.05 |
$1,380,449 |
D/D |
(55,104) |
36,695 |
0 |
% |
|
RDEA |
Ardea Biosciences Inc |
EVP & COO |
|
2011-05-16 |
4 |
AS |
$25.29 |
$8,548 |
D/D |
(335) |
19,734 |
0 |
- |
|
95 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|